Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells
Open Access
- 1 March 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (10) , 8076-8082
- https://doi.org/10.1074/jbc.m111501200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiationLeukemia, 2001
- Full Oncogenic Activities of v-Src Are Mediated by Multiple Signaling PathwaysJournal of Biological Chemistry, 2000
- Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLThe Journal of Experimental Medicine, 2000
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Cell cycle targets of Ras/Raf signallingOncogene, 1998
- Regulation of the Fas Apoptotic Cell Death Pathway by AblPublished by Elsevier ,1995
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994
- Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitroScience, 1992
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990